Treatment of proliferative diseases with epothilone derivatives and radiation

Details for Australian Patent Application No. 2008200555 (hide)

Owner Novartis AG

Inventors Pruschy, Martin

Agent Davies Collison Cave

Pub. Number AU-B-2008200555

Parent 2004218927

Filing date 6 February 2008

Wipo publication date 28 February 2008

Acceptance publication date 14 April 2011

International Classifications

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 41/00 (2006.01) Medicinal preparations obtained by treating materials with wave energy or particle radiation

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

21 February 2008 Complete Application Filed

28 February 2008 Application Open to Public Inspection

  Published as AU-B-2008200555

14 April 2011 Application Accepted

  Published as AU-B-2008200555

25 August 2011 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 26 Jul 2011. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

15 December 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 26 Jul 2011

22 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008200556-A support for concrete reinforcing

2008200554-Vehicle air conditioning and heating system providing engine on and off operation